Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1968 1
1969 1
1971 1
1972 2
1973 4
1974 2
1975 2
1976 7
1977 4
1978 5
1979 1
1980 1
1981 4
1982 5
1983 4
1984 3
1985 2
1986 3
1987 2
1988 5
1989 3
1990 6
1991 8
1992 3
1993 6
1994 15
1995 17
1996 31
1997 22
1998 26
1999 40
2000 56
2001 65
2002 91
2003 111
2004 100
2005 140
2006 295
2007 434
2008 509
2009 529
2010 474
2011 533
2012 540
2013 563
2014 631
2015 599
2016 560
2017 573
2018 606
2019 603
2020 678
2021 805
2022 798
2023 778
2024 302

Text availability

Article attribute

Article type

Publication date

Search Results

10,592 results

Results by year

Filters applied: . Clear all
Page 1
HPV Vaccination and the Risk of Invasive Cervical Cancer.
Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, Sundström K, Dillner J, Sparén P. Lei J, et al. N Engl J Med. 2020 Oct 1;383(14):1340-1348. doi: 10.1056/NEJMoa1917338. N Engl J Med. 2020. PMID: 32997908
However, data to inform the relationship between quadrivalent HPV vaccination and the subsequent risk of invasive cervical cancer are lacking. ...RESULTS: During the study period, we evaluated girls and women for cervical cancer until their 31st …
However, data to inform the relationship between quadrivalent HPV vaccination and the subsequent risk of invasive cervical
Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer.
Kjaer SK, Dehlendorff C, Belmonte F, Baandrup L. Kjaer SK, et al. J Natl Cancer Inst. 2021 Oct 1;113(10):1329-1335. doi: 10.1093/jnci/djab080. J Natl Cancer Inst. 2021. PMID: 33876216 Free PMC article.
From nationwide registries, information on HPV vaccination and cervical cancer diagnoses were retrieved. Incidence rate ratios (IRRs) with 95% confidence intervals (CIs) for cervical cancer according to vaccination status were estimated u …
From nationwide registries, information on HPV vaccination and cervical cancer diagnoses were retrieved. Incidence rate …
Human Papilloma Virus Vaccination.
Rosalik K, Tarney C, Han J. Rosalik K, et al. Viruses. 2021 Jun 8;13(6):1091. doi: 10.3390/v13061091. Viruses. 2021. PMID: 34201028 Free PMC article. Review.
While vaccination is readily accessible in more developed countries, barriers exist to worldwide distribution and acceptance of vaccination. ...Despite these advancements, and the data supporting their efficacy, there has been substantial delay in obtaining adequate …
While vaccination is readily accessible in more developed countries, barriers exist to worldwide distribution and acceptance of va
HPV vaccination in Papua New Guinea to prevent cervical cancer in women: Gender, sexual morality, outsiders and the de-feminization of the HPV vaccine.
Kelly-Hanku A, Newland J, Aggleton P, Ase S, Aeno H, Fiya V, Vallely LM, Toliman PJ, Mola GD, Kaldor JM, Vallely AJ. Kelly-Hanku A, et al. Papillomavirus Res. 2019 Dec;8:100171. doi: 10.1016/j.pvr.2019.100171. Epub 2019 Jun 15. Papillomavirus Res. 2019. PMID: 31212024 Free PMC article. Review.
Papua New Guinea has among the highest estimated burden of cervical cancer globally, but currently lacks national cervical screening or human papillomavirus (HPV) vaccination programmes. ...There was strong community support for the introduction of the …
Papua New Guinea has among the highest estimated burden of cervical cancer globally, but currently lacks national cervical
Human papillomavirus vaccine effectiveness by age at vaccination: A systematic review.
Ellingson MK, Sheikha H, Nyhan K, Oliveira CR, Niccolai LM. Ellingson MK, et al. Hum Vaccin Immunother. 2023 Aug 1;19(2):2239085. doi: 10.1080/21645515.2023.2239085. Hum Vaccin Immunother. 2023. PMID: 37529935 Free PMC article. Review.
We conducted a systematic review of HPV vaccine effectiveness studies published between 2007 and 2022 that included an analysis of effectiveness against vaccine-type HPV infections, anogenital warts, cervical abnormalities and cervical cancer by …
We conducted a systematic review of HPV vaccine effectiveness studies published between 2007 and 2022 that included an analysis of ef …
Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study.
Simms KT, Hanley SJB, Smith MA, Keane A, Canfell K. Simms KT, et al. Lancet Public Health. 2020 Apr;5(4):e223-e234. doi: 10.1016/S2468-2667(20)30010-4. Epub 2020 Feb 10. Lancet Public Health. 2020. PMID: 32057317 Free article.
We adapted the model for Japan with use of data on HPV prevalence, screening practices and coverage, and cervical cancer incidence and mortality. We evaluated the expected number of cervical cancer cases and deaths over the lifetime of cohorts born fro …
We adapted the model for Japan with use of data on HPV prevalence, screening practices and coverage, and cervical cancer incid …
Knowledge of Cervical Cancer and Human Papillomavirus among Japanese Women.
Nakao Y, Sasaki AI, Obara T, Abe S, Furusaki K, Higaki M, Yoshimachi S, Gotou T. Nakao Y, et al. Asian Pac J Cancer Prev. 2020 Dec 1;21(12):3527-3532. doi: 10.31557/APJCP.2020.21.12.3527. Asian Pac J Cancer Prev. 2020. PMID: 33369448 Free PMC article.
BACKGROUND: The combination of human papillomavirus (HPV) vaccination and cervical cancer tests are globally recommended. Although knowledge regarding cervical cancer and HPV and experience of HPV vaccination are reportedly closely associ …
BACKGROUND: The combination of human papillomavirus (HPV) vaccination and cervical cancer tests are globally recommende …
Mapping Evidence on Management of Cervical Cancer in Sub-Saharan Africa: Scoping Review.
Zibako P, Hlongwa M, Tsikai N, Manyame S, Ginindza TG. Zibako P, et al. Int J Environ Res Public Health. 2022 Jul 28;19(15):9207. doi: 10.3390/ijerph19159207. Int J Environ Res Public Health. 2022. PMID: 35954564 Free PMC article. Review.
Cervical cancer (CC) is the most common viral infection of the reproductive tract and in Sub-Saharan Africa (SSA), its morbidity and mortality rates are high. ...Research projects assessing knowledge, attitude and practice of those in immediate care of girls at v
Cervical cancer (CC) is the most common viral infection of the reproductive tract and in Sub-Saharan Africa (SSA), its morbidi
A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
Jenkins D. Jenkins D. Gynecol Oncol. 2008 Sep;110(3 Suppl 1):S18-25. doi: 10.1016/j.ygyno.2008.06.027. Epub 2008 Jul 23. Gynecol Oncol. 2008. PMID: 18653221 Review.
HPV-18 and -45, along with HPV-16, are found in over 90% of endocervical adenocarcinomas. HPV-45 is the third most frequent HPV type in cervical carcinoma and adenocarcinoma. The AS04-adjuvanted vaccine Cervarix was developed against HPV-16 and -18 focusing on preve …
HPV-18 and -45, along with HPV-16, are found in over 90% of endocervical adenocarcinomas. HPV-45 is the third most frequent HPV type in c
10,592 results
You have reached the last available page of results. Please see the User Guide for more information.